Med Life S.A. (FRA:O0C)
| Market Cap | 1.15B +65.7% |
| Revenue (ttm) | 637.03M +14.2% |
| Net Income | 1.50M -68.0% |
| EPS | 0.00 -68.4% |
| Shares Out | n/a |
| PE Ratio | 767.63 |
| Forward PE | 45.93 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 2.080 |
| Previous Close | 2.065 |
| Day's Range | 2.080 - 2.130 |
| 52-Week Range | 1.240 - 2.870 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |
About Med Life
Med Life S.A., a private healthcare provider, provides integrated medical services through its clinics and hospitals in Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging tests; day hospitalization services; hospitalization and surgical treatment services; medical and surgical specialties; maternal and child health dedicated services; and stem cell bank. It also provides laboratory services, such as biochemistry, pathological anatomy, molecul... [Read more]
Financial Performance
In 2025, Med Life's revenue was 3.17 billion, an increase of 16.86% compared to the previous year's 2.72 billion. Earnings were 11.27 million, a decrease of -55.00%.
Financial numbers in RON Financial StatementsNews
Med Life Earnings Call Transcript: Q1 2026
Q1 2026 saw 10% revenue growth and a 90% rise in net profit, driven by strong demand and expansion in clinics, hospitals, and labs. Margin improvement is expected through the year, with a focus on digitalization and personalized medicine.
Med Life Quarterly report: Q1 2026
Med Life has published its Q1 2026 quarterly earnings report on May 29, 2026.
Med Life Slides: Q1 2026
Med Life has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 29, 2026.
Med Life Quarterly report: Q4 2025
Med Life has published its Q4 2025 quarterly earnings report on February 27, 2026.
Med Life Slides: Q4 2025
Med Life has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 27, 2026.
Med Life Earnings Call Transcript: Q3 2025
Turnover grew 19.5% to RON 2.36 billion in the first nine months, with hospitals and clinics leading growth. EBITDA rose 20.4%, but net profit dropped 88% due to FX losses. Investments focused on new facilities, AI, and genetic testing, while debt and CapEx were closely managed.
Med Life Quarterly report: Q3 2025
Med Life has published its Q3 2025 quarterly earnings report on November 14, 2025.
Med Life Slides: Q3 2025
Med Life has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 14, 2025.
Med Life Earnings Call Transcript: Q2 2025
Turnover grew 20% to RON 1.57 billion in H1 2025, with 16% organic growth and strong EBITDA margin. Major acquisitions, tech investments, and new hospital units drove expansion, while FX losses and fiscal changes weighed on net results.
Med Life Quarterly report: Q2 2025
Med Life has published its Q2 2025 quarterly earnings report on August 29, 2025.
Med Life Slides: Q2 2025
Med Life has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 29, 2025.